Chimeric SFT2D2-TBX19 and Prostate Cancer Progression
Author Information
Author(s): Hu Chenxi, Zheng Zaosong, Pang Shiyu, Zhu Yuanchao, Jie Jirong, Lai Zhuocheng, Zeng Xiangbo, Xiao Yongyuan, Chen Zhifeng, Zhao Jingjing, Du Yuejun, Li Fei, Wang Qiong, Tan Wanlong
Primary Institution: Southern Medical University
Hypothesis
Does the chimeric RNA SFT2D2-TBX19 promote prostate cancer progression through its encoded protein TBX19-202 and stabilization of mitochondrial ATP synthase?
Conclusion
The study provides evidence that chimeric SFT2D2-TBX19 promotes prostate cancer progression by encoding the TBX19-202 protein and stabilizing mitochondrial ATP synthase via ATP5F1A phosphorylation.
Supporting Evidence
- SFT2D2-TBX19 was validated as highly expressed in 21 paired tumor samples from prostate cancer patients.
- Overexpression of SFT2D2-TBX19 promoted cell proliferation, migration, and invasion.
- SFT2D2-TBX19 knockdown inhibited cancer cell proliferation and migration.
- SFT2D2-TBX19 interacts with ATP5F1A and ATP5F1B, stabilizing ATP synthase activity.
- SFT2D2-TBX19 protects mitochondrial function under stress conditions.
Takeaway
A new RNA called SFT2D2-TBX19 helps prostate cancer grow by making a protein and keeping energy factories in the cells working well.
Methodology
The study involved screening and validating chimeric RNAs in prostate cancer cell lines, followed by functional assays to assess the effects of SFT2D2-TBX19 on cell proliferation, migration, and invasion.
Participant Demographics
Prostate cancer patients from whom tumor samples were collected.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website